ELUSYS HOLDINGS INC. – Trademark Portfolio

Entity Type: 03

ELUSYS HOLDINGS INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include NIGHTHAWK BIOSCIENCES. The owner is based in PINE BROOK, NJ.

25 RIVERSIDE DRIVE, UNIT 1

PINE BROOK, NJ 07058

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ELUSYS HOLDINGS INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does ELUSYS HOLDINGS INC. have?

ELUSYS HOLDINGS INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 1 abandoned.

What trademark classes does ELUSYS HOLDINGS INC. file in?

ELUSYS HOLDINGS INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ELUSYS HOLDINGS INC.'s most well-known trademarks?

ELUSYS HOLDINGS INC.'s registered trademark portfolio includes well-known marks such as NIGHTHAWK BIOSCIENCES. These are among 1 currently registered trademark in the portfolio.

What is ELUSYS HOLDINGS INC.'s trademark registration success rate?

ELUSYS HOLDINGS INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.